-
BTAI Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
BioXcel Therapeutics (BTAI)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 40.39 mm | 40.39 mm | 40.39 mm | 40.39 mm | 40.39 mm | 40.39 mm |
Cash burn (monthly) | 5.29 mm | 4.13 mm | 5.10 mm | 6.39 mm | 5.45 mm | 7.01 mm |
Cash used (since last report) | 26.90 mm | 20.99 mm | 25.90 mm | 32.45 mm | 27.67 mm | 35.60 mm |
Cash remaining | 13.48 mm | 19.40 mm | 14.49 mm | 7.94 mm | 12.72 mm | 4.78 mm |
Runway (months of cash) | 2.5 | 4.7 | 2.8 | 1.2 | 2.3 | 0.7 |
13F holders | Current |
---|---|
Total holders | 53 |
Opened positions | 5 |
Closed positions | 29 |
Increased positions | 7 |
Reduced positions | 27 |
13F shares | Current |
---|---|
Total value | 1.99 bn |
Total shares | 19.34 mm |
Total puts | 40.20 k |
Total calls | 22.20 k |
Total put/call ratio | 1.8 |
Largest owners | Shares | Value |
---|---|---|
BioXcel | 8.55 mm | $163.24 mm |
BioXcel | 7.69 mm | $0.00 |
Vanguard | 1.20 mm | $732.84 mm |
BlackRock | 362.49 k | $221.12 mm |
Geode Capital Management | 298.04 k | $181.84 mm |
WFC Wells Fargo & Company | 185.06 k | $112.89 mm |
Renaissance Technologies | 129.87 k | $79.22 mm |
Millennium Management | 128.77 k | $78.55 mm |
BAC Bank of America | 83.70 k | $51.06 mm |
STT State Street | 77.15 k | $47.06 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Jan 25 | David J. Mack | Common Stock | Option exercise | Acquire M | No | No | 0 | 27,089 | 0.00 | 81,267 |
31 Jan 25 | David J. Mack | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 27,089 | 0.00 | 243,810 |
15 Jan 25 | Rajiv Patni | Stock Option Common Stock | Grant | Acquire A | No | No | 0.3465 | 44,000 | 15.25 k | 44,000 |
7 Jan 25 | Yocca Frank | Stock Option Common Stock | Grant | Acquire A | No | No | 0.4713 | 270,000 | 127.25 k | 270,000 |
7 Jan 25 | Mehta Vimal | Stock Option Common Stock | Grant | Acquire A | No | No | 0.4713 | 660,000 | 311.06 k | 660,000 |